[1]杨元利,张永峰,李爱芳,等.脑脊液腺苷脱氨酶水平检测在结核性脑膜炎早期诊断中的价值[J].陕西医学杂志,2022,51(3):363-365,369.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.023]
 YANG Yuanli,ZHANG Yongfeng,LI Aifang,et al.Value of adenosine deaminase level in cerebrospinal fluid in early diagnosis of tuberculous meningitis[J].,2022,51(3):363-365,369.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.023]
点击复制

脑脊液腺苷脱氨酶水平检测在结核性脑膜炎早期诊断中的价值
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年3期
页码:
363-365,369
栏目:
临床检验
出版日期:
2022-03-05

文章信息/Info

Title:
Value of adenosine deaminase level in cerebrospinal fluid in early diagnosis of tuberculous meningitis
作者:
杨元利张永峰李爱芳杜苏丰任 斐党丽云杨 翰
(西安市胸科医院,陕西 西安 710100)
Author(s):
YANG YuanliZHANG YongfengLI AifangDU SufengREN FeiDANG LiyunYANG Han
(Xi'an Chest Hospital,Xi'an 710100,China)
关键词:
结核性脑膜炎 腺苷脱氨酶 脑脊液 早期诊断价值 受试者工作特征曲线
Keywords:
Tuberculous meningitis Adenosine deaminase Cerebrospinal fluid Early diagnostic value Receiver operating characteristic curve
分类号:
R 529.3
DOI:
DOI:10.3969/j.issn.1000-7377.2022.03.023
文献标志码:
A
摘要:
目的:探讨脑脊液(CSF)中腺苷脱氨酶(ADA)水平检测在结核性脑膜炎(TBM)早期诊断中的价值。方法:收集以头痛、发热、精神状态改变和脑膜刺激征为特征的疑似TBM患者65例为研究对象。根据确诊结果将所有患者分为TBM组(45例)和非TBM组(20例)。所有患者在住院后2周内进行腰椎穿刺术,留取CSF,检测并比较两组患者CSF中ADA水平。采用受试者工作特征(ROC)曲线评估ADA对TBM的早期诊断价值。结果:TBM组CSF中ADA水平在3~26 U/L,中位数(四分位数间距)为8(6,10)U/L。非TBM组CSF中ADA水平在0~5 U/L,中位数(四分位数间距)为1(0,2.75)U/L。TBM组患者CSF中ADA水平高于非TBM组(Z=-6.176,P<0.05)。ROC曲线分析结果显示,当CSF中ADA水平为4.5 U/L时,其诊断TBM的曲线下面积(AUC)为0.98,敏感度为93.33%,特异度为90.00%。结论:TBM患者CSF中ADA水平升高,在TBM早期诊断中具有较高的敏感性和特异性。
Abstract:
Objective:To investigate the value of adenosine deaminase(ADA)level in cerebrospinal fluid(CSF)in the early diagnosis of tuberculous meningitis(TBM).Methods:A total of 65 patients with suspected TBM characterized by headache,fever,mental state changes and meningeal irritation signs were collected.All patients were divided into TBM group(45 cases)and non TBM group(20 cases).All patients underwent lumbar puncture within 2 weeks after hospitalization,CSF was retained,and the level of ADA in CSF was detected and compared between the two groups.The receiver operating characteristic(ROC)curve was used to evaluate the value of ADA in the early diagnosis of TBM.Results:The level of ADA in CSF of TBM group was 3 to 26 U/L,and the median(interquartile interval)was 8(6,10)U/L.The level of ADA in CSF of non TBM group was 0 to 5 U/L,and the median(interquartile interval)was 1(0,2.75)U/L.The level of ADA in CSF in TBM group was higher than that in non TBM group(Z=-6.176,P<0.05).ROC curve analysis showed that when the ADA level in CSF was 4.5 U/L,the area under the curve(AUC)for the diagnosis of TBM was 0.98,the sensitivity was 93.33%,and the specificity was 90.00%.Conclusion:The level of ADA in CSF of patients with TBM is increased,which has high sensitivity and specificity in the early diagnosis of TBM.

参考文献/References:

[1] 李晓晓,梁亚萍,赵 涛,等.结核病患者422例耐药情况调查研究[J].陕西医学杂志,2020,49(2):250-253.
[2] Rock RB,Olin M,Baker CA,et al.Central nervous system tuberculosis:Pathogenesis and clinical aspects[J].Clinical Microbiology Reviews,2008,21(2):243-261.
[3] 孟艺哲,卜彩霞,陈颜强.不同剂量地塞米松联合异烟肼鞘内注射治疗结核性脑膜炎临床研究[J].陕西医学杂志,2017,46(12):1777-1778.
[4] Ho J,Marais BJ,Gilbert GL,et al.Diagnosing tuberculous meningitis have we made any progress? [J].Trop Med Int Heal,2013,18:783-793.
[5] Almeida SM,Furlan SMP,Cretella AMM,et al.Comparison of cerebrospinal fluid biomarkers for differential diagnosis of acute bacterial and viral meningitis with atypical cerebrospinal fluid characteristics[J].Med Princ Pract,2020,29:244-254.
[6] Thwaites GE,Chau TT,Farrar JJ.Improving the bacteriological diagnosis of tuberculous meningitis[J].Journal of Clinical Microbiology,2004,42(1):378-379.
[7] Wilkinson RJ,Rohlwink U,Misra UK,et al.Tuberculous meningitis[J].Nat Rev Neurol,2017,13(10):581-598.
[8] Mai NT,Thwaites GE.Recent advances in the diagnosis and management of tuberculous meningitis[J].Current Opinion in Infectious Diseases,2017,30(1):123-128.
[9] 李雪莲,马丽萍,陈红梅,等.脑脊液中腺苷脱氨酶水平对结核性脑膜炎的诊断价值[J].中华结核和呼吸杂志,2017,40(5):339-342.
[10] Marais S,Thwaites G,Schoeman JF,et al.Tuberculous meningitis:A uniform case definition for use in clinical research[J].Lancet Infect Dis,2010,10(11):803-812.
[11] 赵雁林,刘宇红,姜广路,等.中国结核病防治规划痰涂片镜检标准化操作及质量保证手册[M].北京:中国协和医科大学出版社,2008:1-51.
[12] 王黎霞.结核分枝杆菌药物敏感性试验标准化操作程序及质量保证手册[M].北京:人民卫生出版社,2013:1-40.
[13] Bahr NC,Marais S,Caws M,et al.GeneXpert MTB/Rif to diagnose tuberculous meningitis:Perhaps the First test but not the last[J].Clin Infect Dis,2016,62:1133-1135.
[14] Lekhak SP,Sharma L,Rajbhandari R,et al.Evaluation of multiplex PCR using MPB64 and IS6110 primers for rapid diagnosis of tuberculous meningitis[J].Tuberculosis,2016,100:1-4.
[15] Xu HB,Jiang RH,Li L,et al.Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis:A meta-analysis[J].Int J Tuberc Lung Dis,2010,14(11):1382-1387.
[16] Tuon FF,Higashino HR,Lopes MI,et al.Adeenosine deaminase and tuberculous meningitis:A systematic review with meta-analysis[J].Scand J Infect Dis,2010,42(3):198-207.
[17] Pormohammad A,Riahi SM,Nasiri MJ,et al.Diagnositc test accuracy of adenosine deaminase for tuber culous meningitis:A systematic review and meta-analysis[J].J Infect,2017,74(6):545-554.
[18] Moghtaderi A,Niazi A,Alavi-Naini R,et al.Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis[J].Clin Neurol Neurosurg,2010,112(6):459-462.
[19] 张苏宁,赵守松,崔 琢.30例结核性脑膜炎的临床特点及治疗[J].中华全科医学,2013,11(11):1734,1744.
[20] Fujiwara S,Mimura N,Yoshimura H,et al.Elevated adenosine deaminase levels in the cerebrospinal fluid in immune checkpoint inhibitor-induced autoimmune encephalitis[J].Intern Med,2019,58(19):2871-2874.

相似文献/References:

[1]王科文,吴胜波,马纪龙,等.三种方法联合检测诊断结核性胸腔积液60例临床研究*[J].陕西医学杂志,2020,49(10):1347.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.039]
[2]方 圆,赵 峰,陈 佩,等.胸腔积液结核分枝杆菌感染T细胞检测对结核性胸膜炎的诊断价值研究*[J].陕西医学杂志,2020,49(12):1681.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.038]
 FANG Yuan,ZHAO Feng,CHEN Pei,et al.Value of T-SPOT.TB assay from pleural fIuid in diagnosis of tuberculous pleurisy[J].,2020,49(3):1681.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.038]
[3]杨 翰,李爱芳,张永峰,等.结核性脑膜炎分子诊断研究进展[J].陕西医学杂志,2021,50(11):1457.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.034]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(2020SF-109)
更新日期/Last Update: 2022-03-04